Bridger Management’s RxSight RXST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-248,858
Closed -$1.53M 28
2026
Q1
$1.53M Buy
248,858
+88,158
+55% +$732K 1.2% 21
2025
Q4
$1.67M Buy
+160,700
New +$1.61M 1.08% 20
2023
Q2
Sell
-99,100
Closed -$1.65M 34
2023
Q1
$1.65M Buy
+99,100
New +$1.4M 0.61% 23
2022
Q4
Sell
-221,732
Closed -$2.66M 37
2022
Q3
$2.66M Sell
221,732
-109,700
-33% -$1.51M 0.81% 29
2022
Q2
$4.67M Buy
331,432
+132,832
+67% +$1.75M 1.05% 25
2022
Q1
$2.46M Buy
+198,600
New +$2.38M 0.4% 41

Other funds holding RXST

Bridger Management's RXST Position: Q2 2026 in Review

Bridger Management sold out of RxSight (RXST) in Q2 2026, closing a stake of 248,858 shares — an estimated $1.53M sold.

Bridger Management first reported a position in RXST in Q1 2022 and held it in 6 quarters. The position peaked at $4.67M in Q2 2022. 151 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

  • Bridger Management reported no remaining RxSight position as of Q2 2026 after selling out during the quarter.
  • Bridger Management sold 248,858 RxSight shares in Q2 2026, an estimated $1.53M.
  • Bridger Management first reported a position in RxSight in Q1 2022 and held it in 6 quarters.
  • Bridger Management's RxSight position peaked at $4.67M in Q2 2022.
  • 151 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on Bridger Management's 13F filing for Q2 2026, filed 18 Aug 2026.